EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Predictive Value of Pyroptosis Markers (NLRP3, HMGB1, and Caspase‐1) in the Prognosis of Patients With Metastatic Breast Cancer: A Prospective Observational Study

Yi Zhang iD, Ying He iD, Qiang Liu iD, Hongwu Deng iD

The Breast Journal · 2025

DOI: 10.1155/tbj/8821116 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Breast Journal, 2025. Verfasst von Yi Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Breast Surgery, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Chang…. Hauptthemen laut MEDLINE: HMGB1 Protein, Breast Neoplasms, Pyroptosis, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The predictive value of serum pyroptosis markers, including NOD‐like receptor family pyrin domain containing 3 (NLRP3), high mobility group box 1 (HMGB1), and caspase‐1, in metastatic breast cancer (MBC) patients was investigated.

Methods

A prospective observational study was conducted, enrolling MBC patients who had not undergone prior radiotherapy or chemotherapy. Serum levels of pyroptosis markers (NLRP3, HMGB1, and caspase‐1) and conventional tumor markers, including carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and cancer antigen 15‐3 (CA15‐3), were measured using enzyme‐linked immunosorbent assay (ELISA) kits. Demographic and clinical data were collected, including age, tumor size, hormone receptor status, and metastatic sites. Patients were followed up for 24 months, and overall survival (OS) was recorded.

Results

The study included 122 MBC patients, categorized into the favorable and poor prognosis groups based on 24‐month survival. Elevated levels of NLRP3 and HMGB1 were significantly associated with poor prognosis, whereas lower levels of caspase‐1 were observed in patients with unfavorable outcomes. Receiver operating characteristic (ROC) curve analysis demonstrated that pyroptosis markers, particularly caspase‐1, had significant predictive value for MBC prognosis. Kaplan–Meier curves showed that patients with high HMGB1 levels had a shorter 24‐month OS, whereas those with low caspase‐1 levels also exhibited a shorter 24‐month OS. Multivariate logistic regression analysis identified tumor diameter, Ki67, molecular subtype, number of metastatic sites per patient, and HMGB1 were independent risk factors for poor prognosis in MBC patients, whereas caspase‐1 was an independent protective factor against poor prognosis.

Conclusion

Serum pyroptosis markers (HMGB1 and caspase‐1) were valuable prognostic indicators in MBC patients. Elevated HMGB1 levels, along with reduced caspase‐1 levels, were associated with poorer outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinBreast NeoplasmsPyroptosisBiomarkers, TumorNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1HumansFemaleMiddle AgedProspective StudiesPrognosisAdultAgedPredictive Value of Tests

Stichwörter der Autor:innen

HMGB1NLRP3caspase-1metastatic breast cancerprognosispyroptosisserum biomarkers

Substanzen

HMGB1 ProteinBiomarkers, TumorNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1HMGB1 protein, humanNLRP3 protein, human

Autor:innen und Institutionen

  • The Second Department of Breast Surgery, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, Hunan, China, csu.edu.cn.

ORCID-Profile: Yi Zhang, Ying He, Qiang Liu, Hongwu Deng

Zitieren

APA

Zhang, Y., He, Y., Liu, Q., & Deng, H. (2025). Predictive Value of Pyroptosis Markers (NLRP3, HMGB1, and Caspase‐1) in the Prognosis of Patients With Metastatic Breast Cancer: A Prospective Observational Study. The Breast Journal. https://doi.org/10.1155/tbj/8821116

Vancouver

Zhang Y, He Y, Liu Q, Deng H. Predictive Value of Pyroptosis Markers (NLRP3, HMGB1, and Caspase‐1) in the Prognosis of Patients With Metastatic Breast Cancer: A Prospective Observational Study. The Breast Journal. 2025. doi:10.1155/tbj/8821116

BibTeX
@article{Zhang2025,
  author = {Zhang, Yi and He, Ying and Liu, Qiang and Deng, Hongwu},
  title = {Predictive Value of Pyroptosis Markers (NLRP3, HMGB1, and Caspase‐1) in the Prognosis of Patients With Metastatic Breast Cancer: A Prospective Observational Study},
  journal = {The Breast Journal},
  year = {2025},
  doi = {10.1155/tbj/8821116}
}
Kostenlos starten →